PGD2 receptor antagonists for the treatment of inflammatory diseases
US7211672B2 · kind B2 · utility
7Cited by
14References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2003 |
| Grant date | May 1, 2007 |
| Priority date | — |
| Expiry date | Nov 2, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds represented by Structural Formula (I): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.